Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells-Reference-Cited by-同舟云学术

Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells

Published:2014-07 Issue:7 Volume:16 Page:946-964
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Eyrich Matthias,Schreiber Susanne C.,Rachor Johannes,Krauss Jürgen,Pauwels Femke,Hain Johannes,Wölfl Matthias,Lutz Manfred B.,de Vleeschouwer Steven,Schlegel Paul G.,Van Gool Stefaan W.

Funder

IZKF

BayImmuNet

Olivia Hendrickx Research Fund

Herman Memorial Research Fund

James E. Kearney Foundation

CAF Belgium, Baxter

IWT (TBM projects)

Stem Cell Institute Leuven

Emmanuel van der Schueren Fund

International Union Against Cancer

klinisch Onderzoeksfonds UZ Leuven

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference60 articles.

1. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors;Ashley;J Exp Med,1997

2. New perspectives in glioma immunotherapy;Daga;Curr Pharm Des,2011

3. Dendritic cell vaccination in pediatric gliomas: lessons learnt and future perspectives;Eyrich;Front Pediatr,2013

4. Immunotherapy approaches for malignant glioma from 2007 to 2009;Johnson;Curr Neurol Neurosci Rep,2010

5. Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours;Ardon;Pediatr Blood Cancer,2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products;Cytotherapy;2024-07

2. Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients;Methods in Cell Biology;2023

3. Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center;Vaccines;2022-06-23

4. Engineering microenvironments for manufacturing therapeutic cells;Experimental Biology and Medicine;2021-07-11

5. Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged;Cancers;2020-12-24